Nasal COVID-19 vaccine heads for human testing
Researchers in Germany said a trial of COVID-19 vaccination administered through the nose has shown great promise in animal testing and is now preparing for Phase I clinical trials in humans.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Clinical Trials | Covid Vaccine | COVID-19 | Germany Health | Health | Vaccines | Veterinary Vaccinations